Cargando…
Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial
PURPOSE: Topical cosmetic agents if correctly prescribed and used may improve outcomes in acne therapy. The aim of this study was to assess the efficacy and tolerability of a new daily cosmetic regimen in the treatment of mild facial acne. PATIENTS AND METHODS: A multicenter, prospective, observatio...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997230/ https://www.ncbi.nlm.nih.gov/pubmed/32099436 http://dx.doi.org/10.2147/CCID.S206935 |
_version_ | 1783493652542128128 |
---|---|
author | Dall’Oglio, Federica Fabbrocini, Gabriella Tedeschi, Aurora Donnarumma, Marianna Chiodini, Paolo Micali, Giuseppe |
author_facet | Dall’Oglio, Federica Fabbrocini, Gabriella Tedeschi, Aurora Donnarumma, Marianna Chiodini, Paolo Micali, Giuseppe |
author_sort | Dall’Oglio, Federica |
collection | PubMed |
description | PURPOSE: Topical cosmetic agents if correctly prescribed and used may improve outcomes in acne therapy. The aim of this study was to assess the efficacy and tolerability of a new daily cosmetic regimen in the treatment of mild facial acne. PATIENTS AND METHODS: A multicenter, prospective, observational, clinical study was conducted on 91 adult patients with mild acne. Subjects were instructed to apply a fluid containing Licochalcone A/Salicylic acid/L-Carnitine in the morning and a cream with Licochalcone A/Hydroxy-Complex 10% at bedtime for 8 weeks. The efficacy was clinically evaluated by Global Acne Grading System (GAGS) score and by comedones/papules lesions count and by instrumental assessment (Sebutape(TM)and Reveal Photo Imager/VISIA-CR™ imaging) at baseline, at 4 and 8 weeks. RESULTS: At 4 weeks a statistically significant reduction from baseline of GAGSwas observed. In addition, the mean total count of comedones and papules was significantly reduced by 41% and 45%, respectively, from baseline along with a significant reduction of mean sebum of 47%. At 8 weeks, a further statistically significant reduction from baseline of GAGS, total count of comedones and papules (64% and 71%, respectively), along with an additional sebum reduction of about 52% was also recorded. CONCLUSION: Our results suggest that the daily regimen based on Licochalcone A with Salicylic acid/L-Carnitine as fluid or with Hydroxy-Complex 10% as cream represent an interesting cosmetic approach for treating mild acne. |
format | Online Article Text |
id | pubmed-6997230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-69972302020-02-25 Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial Dall’Oglio, Federica Fabbrocini, Gabriella Tedeschi, Aurora Donnarumma, Marianna Chiodini, Paolo Micali, Giuseppe Clin Cosmet Investig Dermatol Original Research PURPOSE: Topical cosmetic agents if correctly prescribed and used may improve outcomes in acne therapy. The aim of this study was to assess the efficacy and tolerability of a new daily cosmetic regimen in the treatment of mild facial acne. PATIENTS AND METHODS: A multicenter, prospective, observational, clinical study was conducted on 91 adult patients with mild acne. Subjects were instructed to apply a fluid containing Licochalcone A/Salicylic acid/L-Carnitine in the morning and a cream with Licochalcone A/Hydroxy-Complex 10% at bedtime for 8 weeks. The efficacy was clinically evaluated by Global Acne Grading System (GAGS) score and by comedones/papules lesions count and by instrumental assessment (Sebutape(TM)and Reveal Photo Imager/VISIA-CR™ imaging) at baseline, at 4 and 8 weeks. RESULTS: At 4 weeks a statistically significant reduction from baseline of GAGSwas observed. In addition, the mean total count of comedones and papules was significantly reduced by 41% and 45%, respectively, from baseline along with a significant reduction of mean sebum of 47%. At 8 weeks, a further statistically significant reduction from baseline of GAGS, total count of comedones and papules (64% and 71%, respectively), along with an additional sebum reduction of about 52% was also recorded. CONCLUSION: Our results suggest that the daily regimen based on Licochalcone A with Salicylic acid/L-Carnitine as fluid or with Hydroxy-Complex 10% as cream represent an interesting cosmetic approach for treating mild acne. Dove 2019-12-31 /pmc/articles/PMC6997230/ /pubmed/32099436 http://dx.doi.org/10.2147/CCID.S206935 Text en © 2019 Dall’Oglio et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Dall’Oglio, Federica Fabbrocini, Gabriella Tedeschi, Aurora Donnarumma, Marianna Chiodini, Paolo Micali, Giuseppe Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial |
title | Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial |
title_full | Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial |
title_fullStr | Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial |
title_full_unstemmed | Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial |
title_short | Licochalcone A in Combination with Salicylic Acid as Fluid Based and Hydroxy-Complex 10% Cream for the Treatment of Mild Acne: A Multicenter Prospective Trial |
title_sort | licochalcone a in combination with salicylic acid as fluid based and hydroxy-complex 10% cream for the treatment of mild acne: a multicenter prospective trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997230/ https://www.ncbi.nlm.nih.gov/pubmed/32099436 http://dx.doi.org/10.2147/CCID.S206935 |
work_keys_str_mv | AT dallogliofederica licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial AT fabbrocinigabriella licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial AT tedeschiaurora licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial AT donnarummamarianna licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial AT chiodinipaolo licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial AT micaligiuseppe licochalconeaincombinationwithsalicylicacidasfluidbasedandhydroxycomplex10creamforthetreatmentofmildacneamulticenterprospectivetrial |